<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27456172</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><PubDate><Year>2016</Year><Month>Jul</Month><Day>26</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Dengue virus infection induces interferon-lambda1 to facilitate cell migration.</ArticleTitle><Pagination><StartPage>24530</StartPage><MedlinePgn>24530</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">24530</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/srep24530</ELocationID><Abstract><AbstractText>A marked increase in the rate of dengue virus (DENV) infection has resulted in more than 212 deaths in Taiwan since the beginning of 2015, mostly from fatal outcomes such as dengue hemorrhagic fever and dengue shock syndrome. The pathogenic mechanisms of these fatal manifestations are poorly understood. Cytokines induce an overwhelming immune reaction and thus have crucial roles. Interferon-lambda (IFN-&#x3bb;), a newly identified IFN subtype, has antiviral effects, but its immunologic effects in DENV infection have not been investigated. In the present study, we show that DENV infection preferentially induced production of IFN-&#x3bb;1 in human dendritic cells (DCs) and human lung epithelial cells. Virus nonstructural 1 (NS1) glycoprotein was responsible for the effect. DENV-induced production of IFN-&#x3bb;1 was dependent on signaling pathways involving toll-like receptor (TLR)-3, interferon regulation factor (IRF)-3, and nuclear factor-kappaB (NF-&#x3ba;B). Blocking interaction between IFN-&#x3bb;1 and its receptor IFN-&#x3bb;R1 through siRNA interference reduced DENV-induced DC migration towards the chemoattractants CCL19 and CCL21, by inhibiting CCR7 expression. Furthermore, IFN-&#x3bb;1 itself induced CCR7 expression and DC migration. Our study presents the first evidence of the mechanisms and effects of IFN-&#x3bb;1 induction in DENV-infected DCs and highlights the role of this cytokine in the immunopathogenesis of DENV infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Yu-Lin</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Institute of Preventive Medicine, National Defense Medical Center, Taipei, Taiwan, R.O.C.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Mei-Yi</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, Tao-Yuan, Taiwan, R.O.C.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Ling-Jun</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Institute of Cellular and System Medicine, National Health Research Institute, Zhunan, Taiwan, R.O.C.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Jenn-Haung</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, Tao-Yuan, Taiwan, R.O.C.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Clinical Research, National Defense Medical Center, Taipei, Taiwan, R.O.C.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C434003">3-(4-methylphenylsulfonyl)-2-propenenitrile</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054415">Chemokine CCL19</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054421">Chemokine CCL21</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050838">Interferon Regulatory Factor-3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009570">Nitriles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054400">Receptors, CCR7</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013450">Sulfones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051196">Toll-Like Receptor 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000624353">interferon-lambda, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>9008-11-1</RegistryNumber><NameOfSubstance UI="D007372">Interferons</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000072283" MajorTopicYN="N">A549 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054415" MajorTopicYN="N">Chemokine CCL19</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054421" MajorTopicYN="N">Chemokine CCL21</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050838" MajorTopicYN="N">Interferon Regulatory Factor-3</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007372" MajorTopicYN="N">Interferons</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009570" MajorTopicYN="N">Nitriles</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054400" MajorTopicYN="N">Receptors, CCR7</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013450" MajorTopicYN="N">Sulfones</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051196" MajorTopicYN="N">Toll-Like Receptor 3</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27456172</ArticleId><ArticleId IdType="pmc">PMC4960520</ArticleId><ArticleId IdType="doi">10.1038/srep24530</ArticleId><ArticleId IdType="pii">srep24530</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sharmin S., Viennet E., Glass K. &amp; Harley D. The emergence of dengue in Bangladesh: epidemiology, challenges and future disease risk. Trans R Soc Trop Med Hyg 109, 619&#x2013;627 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26333430</ArticleId></ArticleIdList></Reference><Reference><Citation>Laughlin C. A. et al.. Dengue research opportunities in the Americas. J Infect Dis 206, 1121&#x2013;1127 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3499110</ArticleId><ArticleId IdType="pubmed">22782946</ArticleId></ArticleIdList></Reference><Reference><Citation>Paessler S. &amp; Walker D. H. Pathogenesis of the viral hemorrhagic fevers. Annu Rev Pathol 8, 411&#x2013;440 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23121052</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadler A. J. &amp; Williams B. R. Interferon-inducible antiviral effectors. Nat Rev Immunol 8, 559&#x2013;568 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2522268</ArticleId><ArticleId IdType="pubmed">18575461</ArticleId></ArticleIdList></Reference><Reference><Citation>MacMicking J. D. Interferon-inducible effector mechanisms in cell-autonomous immunity. Nat Rev Immunol 12, 367&#x2013;382 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4150610</ArticleId><ArticleId IdType="pubmed">22531325</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotenko S. V. et al.. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4, 69&#x2013;77 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12483210</ArticleId></ArticleIdList></Reference><Reference><Citation>Egli A. et al.. Immunomodulatory Function of Interleukin 28B during primary infection with cytomegalovirus. J Infect Dis 210, 717&#x2013;727 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24620020</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazear H. M., Nice T. J. &amp; Diamond M. S. Interferon-lambda: Immune Functions at Barrier Surfaces and Beyond. Immunity 43, 15&#x2013;28 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4527169</ArticleId><ArticleId IdType="pubmed">26200010</ArticleId></ArticleIdList></Reference><Reference><Citation>Mennechet F. J. &amp; Uze G. Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells. Blood 107, 4417&#x2013;4423 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16478884</ArticleId></ArticleIdList></Reference><Reference><Citation>Durbin R. K., Kotenko S. V. &amp; Durbin J. E. Interferon induction and function at the mucosal surface. Immunol Rev 255, 25&#x2013;39 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5972370</ArticleId><ArticleId IdType="pubmed">23947345</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahlakoiv T., Hernandez P., Gronke K., Diefenbach A. &amp; Staeheli P. Leukocyte-derived IFN-alpha/beta and epithelial IFN-lambda constitute a compartmentalized mucosal defense system that restricts enteric virus infections. PLos Pathog 11, e1004782, 10.1371/journal.ppat.1004782 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004782</ArticleId><ArticleId IdType="pmc">PMC4388470</ArticleId><ArticleId IdType="pubmed">25849543</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldridge M. T. et al.. Commensal microbes and interferon-lambda determine persistence of enteric murine norovirus infection. Science 347, 266&#x2013;269 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4409937</ArticleId><ArticleId IdType="pubmed">25431490</ArticleId></ArticleIdList></Reference><Reference><Citation>Odendall C. et al.. Diverse intracellular pathogens activate type III interferon expression from peroxisomes. Nat Immunol 15, 717&#x2013;726 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4106986</ArticleId><ArticleId IdType="pubmed">24952503</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths S. J., Dunnigan C. M., Russell C. D. &amp; Haas J. G. The Role of Interferon-lambda Locus Polymorphisms in Hepatitis C and Other Infectious Diseases. J Innate Immun 7, 231&#x2013;242 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6738896</ArticleId><ArticleId IdType="pubmed">25634147</ArticleId></ArticleIdList></Reference><Reference><Citation>Manuel O. et al.. Influence of IFNL3/4 polymorphisms on the incidence of cytomegalovirus infection after solid-organ transplantation. J Infect Dis 211, 906&#x2013;914 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25301956</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermant P. &amp; Michiels T. Interferon-lambda in the context of viral infections: production, response and therapeutic implications. J Innate Immun 6, 563&#x2013;574 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6741612</ArticleId><ArticleId IdType="pubmed">24751921</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho L. J. et al.. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol 166, 1499&#x2013;1506 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11160189</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu Y. L., Shi S. F., Wu W. L., Ho L. J. &amp; Lai J. H. Protective Roles of Interferon-Induced Protein with Tetratricopeptide Repeats 3 (IFIT3) in Dengue Virus Infection of Human Lung Epithelial Cells. PLos One 8, e79518, 10.1371/journal.pone.0079518 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0079518</ArticleId><ArticleId IdType="pmc">PMC3817122</ArticleId><ArticleId IdType="pubmed">24223959</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz-Jordan J. L., Sanchez-Burgos G. G., Laurent-Rolle M. &amp; Garcia-Sastre A. Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci USA 100, 14333&#x2013;14338 (2003).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC283592</ArticleId><ArticleId IdType="pubmed">14612562</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta E. G., Castilla V. &amp; Damonte E. B. Alternative infectious entry pathways for dengue virus serotypes into mammalian cells. Cell Microbiol 11, 1533&#x2013;1549 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7162254</ArticleId><ArticleId IdType="pubmed">19523154</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis I., Ye F., McNally B., Willette M. &amp; Flano E. Toll-like receptor expression and induction of type I and type III interferons in primary airway epithelial cells. J Virol 87, 3261&#x2013;3270 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3592129</ArticleId><ArticleId IdType="pubmed">23302870</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W. L., Ho L. J., Chang D. M., Chen C. H. &amp; Lai J. H. Triggering of DC migration by dengue virus stimulation of COX-2-dependent signaling cascades in vitro highlights the significance of these cascades beyond inflammation. Eur J Immunol 39, 3413&#x2013;3422 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19862774</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu Y. L., Wang M. Y., Ho L. J., Huang C. Y. &amp; Lai J. H. Up-regulation of galectin-9 induces cell migration in human dendritic cells infected with dengue virus. J Cell Mol Med 19, 1065&#x2013;1076 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4420608</ArticleId><ArticleId IdType="pubmed">25754930</ArticleId></ArticleIdList></Reference><Reference><Citation>Palma-Ocampo H. K. et al.. Interferon lambda inhibits dengue virus replication in epithelial cells. Virol J 12, 150, 10.1186/s12985-015-0383-4 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-015-0383-4</ArticleId><ArticleId IdType="pmc">PMC4584467</ArticleId><ArticleId IdType="pubmed">26411318</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Z. et al.. Activation of Toll-like receptor 3 impairs the dengue virus serotype 2 replication through induction of IFN-beta in cultured hepatoma cells. PLos One 6, e23346, 10.1371/journal.pone.0023346 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0023346</ArticleId><ArticleId IdType="pmc">PMC3150425</ArticleId><ArticleId IdType="pubmed">21829730</ArticleId></ArticleIdList></Reference><Reference><Citation>Coccia E. M. et al.. Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol 34, 796&#x2013;805 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14991609</ArticleId></ArticleIdList></Reference><Reference><Citation>Iversen M. B., Ank N., Melchjorsen J. &amp; Paludan S. R. Expression of type III interferon (IFN) in the vaginal mucosa is mediated primarily by dendritic cells and displays stronger dependence on NF-kappaB than type I IFNs. J Virol 84, 4579&#x2013;4586 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2863761</ArticleId><ArticleId IdType="pubmed">20181703</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H. C., Narayanan S., Park S. J., Seong S. Y. &amp; Hahn Y. S. Transcriptional regulation of IFN-lambda genes in hepatitis C virus-infected hepatocytes via IRF-3.IRF-7.NF-kappaB complex. J Biol Chem 289, 5310&#x2013;5319 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3931086</ArticleId><ArticleId IdType="pubmed">24385435</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang T. H. et al.. Dengue virus serotype 2 blocks extracellular signal-regulated kinase and nuclear factor-kappaB activation to downregulate cytokine production. PLos One 7, e41635, 10.1371/journal.pone.0041635 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0041635</ArticleId><ArticleId IdType="pmc">PMC3425550</ArticleId><ArticleId IdType="pubmed">22927911</ArticleId></ArticleIdList></Reference><Reference><Citation>Banos-Lara Mdel R. et al.. Impact and regulation of lambda interferon response in human metapneumovirus infection. J Virol 89, 730&#x2013;742 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4301146</ArticleId><ArticleId IdType="pubmed">25355870</ArticleId></ArticleIdList></Reference><Reference><Citation>Audry M. et al.. NEMO is a key component of NF-kappaB- and IRF-3-dependent TLR3-mediated immunity to herpes simplex virus. J Allergy Clin Immunol 128, 610-617 e611-614, 10.1016/j.jaci.2011.04.059 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2011.04.059</ArticleId><ArticleId IdType="pmc">PMC3164951</ArticleId><ArticleId IdType="pubmed">21722947</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcon S. et al.. Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol 40, 376&#x2013;381 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC153354</ArticleId><ArticleId IdType="pubmed">11825945</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng H. J. et al.. Anti-dengue virus nonstructural protein 1 antibodies recognize protein disulfide isomerase on platelets and inhibit platelet aggregation. Mol Immunol 47, 398&#x2013;406 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19822367</ArticleId></ArticleIdList></Reference><Reference><Citation>Avirutnan P. et al.. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J Exp Med 207, 793&#x2013;806 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2856034</ArticleId><ArticleId IdType="pubmed">20308361</ArticleId></ArticleIdList></Reference><Reference><Citation>Green S. &amp; Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis 19, 429&#x2013;436 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16940865</ArticleId></ArticleIdList></Reference><Reference><Citation>Beatty P. R. et al.. Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci Transl Med 7, 304ra141, 10.1126/scitranslmed.aaa3787 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaa3787</ArticleId><ArticleId IdType="pubmed">26355030</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa S. M. et al.. Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence. Vaccine 24, 195&#x2013;205 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16122850</ArticleId></ArticleIdList></Reference><Reference><Citation>Amorim J. H. et al.. Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant. Vaccine 30, 837&#x2013;845 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22178517</ArticleId></ArticleIdList></Reference><Reference><Citation>Modhiran N. et al.. Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Sci Transl Med 7, 304ra142, 10.1126/scitranslmed.aaa3863 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaa3863</ArticleId><ArticleId IdType="pubmed">26355031</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Ng M. M. &amp; Chu J. J. Activation of TLR2 and TLR6 by Dengue NS1 Protein and Its Implications in the Immunopathogenesis of Dengue Virus Infection. PLos Pathog 11, e1005053, 10.1371/journal.ppat.1005053 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005053</ArticleId><ArticleId IdType="pmc">PMC4520596</ArticleId><ArticleId IdType="pubmed">26226614</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid M. A., Diamond M. S. &amp; Harris E. Dendritic cells in dengue virus infection: targets of virus replication and mediators of immunity. Front Immunol 5, 647, 10.3389/fimmu.2014.00647 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00647</ArticleId><ArticleId IdType="pmc">PMC4269190</ArticleId><ArticleId IdType="pubmed">25566258</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinz M. et al.. Nuclear factor kappaB-dependent gene expression profiling of Hodgkin&#x2019;s disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J Exp Med 196, 605&#x2013;617 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2194004</ArticleId><ArticleId IdType="pubmed">12208876</ArticleId></ArticleIdList></Reference><Reference><Citation>Mburu Y. K. et al.. Chemokine receptor 7 (CCR7) gene expression is regulated by NF-kappaB and activator protein 1 (AP1) in metastatic squamous cell carcinoma of head and neck (SCCHN). J Biol Chem 287, 3581&#x2013;3590 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3271011</ArticleId><ArticleId IdType="pubmed">22158872</ArticleId></ArticleIdList></Reference><Reference><Citation>Mucha J., Majchrzak K., Taciak B., Hellmen E. &amp; Krol M. MDSCs mediate angiogenesis and predispose canine mammary tumor cells for metastasis via IL-28/IL-28RA (IFN-lambda) signaling. PLos One 9, e103249, 10.1371/journal.pone.0103249 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0103249</ArticleId><ArticleId IdType="pmc">PMC4116234</ArticleId><ArticleId IdType="pubmed">25075523</ArticleId></ArticleIdList></Reference><Reference><Citation>De La Cruz Hernandez S. I. et al.. A strong interferon response correlates with a milder dengue clinical condition. J Clin Virol 60, 196&#x2013;199 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24793964</ArticleId></ArticleIdList></Reference><Reference><Citation>Pech Torres R. E., Cedillo Rivera R. M., Lorono Pino M. A. &amp; Sanchez Burgos G. G. Serum levels of IFN-beta are associated with days of evolution but not with severity of dengue. J Med Virol 88, 395&#x2013;399 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26252251</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison J., Aguirre S. &amp; Fernandez-Sesma A. Innate immunity evasion by Dengue virus. Viruses 4, 397&#x2013;413 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3347034</ArticleId><ArticleId IdType="pubmed">22590678</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho L. J. et al.. Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell. J Immunol 174, 8163&#x2013;8172 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15944325</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa H. &amp; Barber G. N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674&#x2013;678 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2804933</ArticleId><ArticleId IdType="pubmed">18724357</ArticleId></ArticleIdList></Reference><Reference><Citation>Maringer K. &amp; Fernandez-Sesma A. Message in a bottle: lessons learned from antagonism of STING signalling during RNA virus infection. Cytokine Growth Factor Rev 25, 669&#x2013;679 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4330990</ArticleId><ArticleId IdType="pubmed">25212897</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguirre S. et al.. DENV inhibits type I IFN production in infected cells by cleaving human STING. PLos Pathog 8, e1002934, 10.1371/journal.ppat.1002934 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002934</ArticleId><ArticleId IdType="pmc">PMC3464218</ArticleId><ArticleId IdType="pubmed">23055924</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>